🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Elimination

According to the social media company, the service has removed violative content and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these groups, posts show black plastic parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant health risks”.